Fund Holdings — Kalehua Capital Management LLC

Total Portfolio Value:
$132.40M
Total Bought:
$132.40M
Total Sold:
$0
Net Transaction:
+$132.40M
Securities
▲▼
SharesValue
Q2 2026
▲▼
Q3 2026
▲▼
Change
▲▼
Q2 2026
▲▼
Q3 2026
▲▼
Weight (%)
▲▼
Change
▲▼
Veradermics, Incorporated(MANE)0145,695+145,695$0$17.66M13.34%+$17.66M
Ea Series TrustALPHA ARCH 1 3
ALPHA ARCH 1-3
0148,471+148,471$0$17.58M13.28%+$17.58M
Korsana Biosciences Inc0442,653+442,653$0$14.16M10.70%+$14.16M
X4 Pharmaceuticals Inc03,722,840+3,722,840$0$10.80M8.15%+$10.80M
Aclaris Therapeutics Inc01,832,365+1,832,365$0$9.64M7.28%+$9.64M
Surrozen Inc0286,092+286,092$0$9.21M6.95%+$9.21M
Inhibikase Therapeutics Inc03,821,890+3,821,890$0$7.85M5.93%+$7.85M
Septerna, Inc.(SEPN)0194,544+194,544$0$7.61M5.75%+$7.61M
Betterlife Pharma Inc027,710,000+27,710,000$0$6.68M5.04%+$6.68M
Obsidian Therapeutics Inc0416,649+416,649$0$5.72M4.32%+$5.72M
Inflarx Nv02,921,095+2,921,095$0$5.26M3.97%+$5.26M
Korro Bio, Inc0473,595+473,595$0$4.69M3.54%+$4.69M
Attovia Therapeutics Inc0200,000+200,000$0$3.43M2.59%+$3.43M
Damora Therapeutics, Inc.(DMRA)0139,000+139,000$0$2.96M2.23%+$2.96M
uniQure N.V.SHS(QURE)079,407+79,407$0$1.92M1.45%+$1.92M
Gossamer Bio Inc0139,366+139,366$0$1.65M1.25%+$1.65M
Milestone Pharmaceuticals In01,651,258+1,651,258$0$1.43M1.08%+$1.43M
Leonabio Inc0393,701+393,701$0$1.41M1.06%+$1.41M
Atrium Therapeutics Inc0112,652+112,652$0$932.8K0.70%+$932.8K
Instil Bio Inc099,600+99,600$0$721.1K0.54%+$721.1K
Atyr Pharma Inc01,829,513+1,829,513$0$554.3K0.42%+$554.3K
Kazia Therapeutics LtdADS056,013+56,013$0$537.4K0.41%+$537.4K
Page 1 of 1
Kalehua Capital Management LLC — 13F Holdings — Q3 2026 | TickerTrail